These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28003011)

  • 1. Targeting the Brain with Nanomedicine.
    Rueda F; Cruz LJ
    Curr Pharm Des; 2017; 23(13):1879-1896. PubMed ID: 28003011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral nanomedicine approaches for the treatment of psychiatric illnesses.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    J Control Release; 2016 Feb; 223():137-156. PubMed ID: 26739547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers.
    Poovaiah N; Davoudi Z; Peng H; Schlichtmann B; Mallapragada S; Narasimhan B; Wang Q
    Nanoscale; 2018 Sep; 10(36):16962-16983. PubMed ID: 30182106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-ophthalmology: Applications and considerations.
    Kamaleddin MA
    Nanomedicine; 2017 May; 13(4):1459-1472. PubMed ID: 28232288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
    Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
    Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic applications of nanoparticles in neurodegenerative disorders.
    Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
    Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.
    Zhang W; Mehta A; Tong Z; Esser L; Voelcker NH
    Adv Sci (Weinh); 2021 May; 8(10):2003937. PubMed ID: 34026447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ins and Outs of Nanoparticle Technology in Neurodegenerative Diseases and Cancer.
    Wilson CM; Magnaudeix A; Naves T; Vincent F; Lalloue F; Jauberteau MO
    Curr Drug Metab; 2015; 16(8):609-32. PubMed ID: 26264207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
    Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin coated or conjugated nanomaterials as an active targeting approach in nanomedicine.
    Agwa MM; Sabra S
    Int J Biol Macromol; 2021 Jan; 167():1527-1543. PubMed ID: 33212102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.
    Garg T; Bhandari S; Rath G; Goyal AK
    J Drug Target; 2015 Dec; 23(10):865-87. PubMed ID: 25835469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry].
    Szebeni J
    Neuropsychopharmacol Hung; 2011 Mar; 13(1):15-24. PubMed ID: 21451188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases.
    Cano A; Sánchez-López E; Ettcheto M; López-Machado A; Espina M; Souto EB; Galindo R; Camins A; García ML; Turowski P
    Nanomedicine (Lond); 2020 May; 15(12):1239-1261. PubMed ID: 32370600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Nanomedicine to Brain Tumors: Latest Progress and Achievements.
    Van't Root M; Lowik C; Mezzanotte L
    Curr Pharm Des; 2017; 23(13):1953-1962. PubMed ID: 28025944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Envisioning the Future of Nanomedicines in Management and Treatment of Neurological Disorders.
    Kumar S; Singh P; Sharma S; Pottoo FH; Ali J; Baboota S
    Comb Chem High Throughput Screen; 2021; 24(10):1544-1556. PubMed ID: 33334281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
    Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
    J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.